Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
Christina Cox, Michele Spina, Samantha Ferrari, Luigi Rigacci, Francesco Merli, Francesco Angrilli, Silvia Bolis, Antonino Mulè, Stefano Luminari, Maria Luigia Vigliotti, Ombretta Annibali, Pier Luigi Zinzani, Samantha Pozzi, Guido Gini, Elisabetta Bonifacio, Francesca Pregnolato, Serena Broggi, S. Kovalchuk, Scalzulli Rp, Angela Maria Mamusa, Armando Santoro, Gloria Margiotta-Casaluci, L. Flenghi, Umberto Vitolo, Fondazione Italiana Linfomi
Publikováno v:
Hematological Oncology
Doxorubicin is the most effective single agent in the treatment of non‐Hodgkin's lymphoma (NHL). Its use is limited because of the cardiac toxicity primarily in elderly patients (pts) and in pts with history of cardiac disease. Liposomal doxorubici
Publikováno v:
The Oncologist
This article reports on the association between phase angle, which is measured by bioelectric impedance analysis and reflects cellular integrity and hydration level, and survival in patients with advanced cancer.
Background. Phase angle is a pro
Background. Phase angle is a pro
Autor:
Frederico Costa, Marianne Pavel, Luciana Carvhalo, Hector Vidal Trueba, Louis de Mestier, Anders Sundin, Daniela Pezzutti, Angela Lamarca, Maxime Ronot, Pavan Najran, Joakim Crona, Clarisse Dromain, Carlos López, Marta Opalinska, Regis Otaviano Franca Bezerra, Niklaus Schaefer, Philip Borg, Naik Vietti Violi
Introduction Tumor growth rate (TGR; percent size change per month [%/m]) is postulated to be an early radiological biomarker to overcome limitations of RECIST. This study aimed to assess the impact of TGR in neuroendocrine tumors (NETs) and potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1a870a270d4d702006fbacec162c13
https://europepmc.org/articles/PMC6853102/
https://europepmc.org/articles/PMC6853102/
Publikováno v:
The Oncologist
Lessons Learned Definitive concurrent chemoradiotherapy based on oxaliplatin and endostatin was effective with the objective response rate exceeding 80%, and the treatment-related toxicities were acceptable. The treatment compliance of the current co